These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20424813)

  • 1. [Difficulties in pharmacotherapy of the elderly].
    Burkhardt H; Wehling M
    Internist (Berl); 2010 Jun; 51(6):737-47; quiz 748. PubMed ID: 20424813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Difficulties in pharmacotherapy of the elderly].
    Burkhardt H; Wehling M
    Urologe A; 2011 Mar; 50(3):351-62. PubMed ID: 21409539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse drug reactions in the elderly: What dermatologists should know].
    Kratzsch D; Simon JC; Treudler R
    Hautarzt; 2016 Feb; 67(2):125-31. PubMed ID: 26643292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of adverse drug reactions in older patients].
    Burkhardt H; Wehling M; Gladisch R
    Z Gerontol Geriatr; 2007 Aug; 40(4):241-54. PubMed ID: 17701115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-drug interactions in the elderly : Which ones really matter?].
    Bitter K; Schlender JF; Woltersdorf R
    Internist (Berl); 2016 Jul; 57(7):728-34. PubMed ID: 27294383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Heppner HJ
    Drug Res (Stuttg); 2019 Nov; 69(S 01):S21-S22. PubMed ID: 31731307
    [No Abstract]   [Full Text] [Related]  

  • 9. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy.
    Kratz T; Diefenbacher A
    Dtsch Arztebl Int; 2019 Jul; 116(29-30):508-518. PubMed ID: 31452508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wise therapeutic decisions for older patients.
    Frühwald T
    Wien Med Wochenschr; 2016 Apr; 166(5-6):147-8. PubMed ID: 26883769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacotherapy in the elderly: primum non nocere!].
    Scheen AJ
    Rev Med Liege; 2014; 69(5-6):282-6. PubMed ID: 25065233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future perspectives on the management of polypharmacy.
    Molokhia M; Majeed A
    BMC Fam Pract; 2017 Jun; 18(1):70. PubMed ID: 28587644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy in the elderly from the clinical toxicologist perspective.
    Heppner HJ; Christ M; Gosch M; Mühlberg W; Bahrmann P; Bertsch T; Sieber C; Singler K
    Z Gerontol Geriatr; 2012 Aug; 45(6):473-8. PubMed ID: 22915001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions and polypharmacy in the elderly in general practice.
    Veehof LJ; Stewart RE; Meyboom-de Jong B; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 1999 Sep; 55(7):533-6. PubMed ID: 10501824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria.
    Schuler J; Dückelmann C; Beindl W; Prinz E; Michalski T; Pichler M
    Wien Klin Wochenschr; 2008; 120(23-24):733-41. PubMed ID: 19122984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polypharmacy - Solutions for Enhanced Drug Safety].
    Krause O; Picksak G; Junius-Walker U
    Dtsch Med Wochenschr; 2017 Jul; 142(14):1046-1053. PubMed ID: 28728199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polimedication: applicability of a computer tool to reduce polypharmacy in nursing homes.
    García-Caballero TM; Lojo J; Menéndez C; Fernández-Álvarez R; Mateos R; Garcia-Caballero A
    Int Psychogeriatr; 2018 Jul; 30(7):1001-1008. PubMed ID: 29747709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol.
    Lavan AH; O'Mahony D; Gallagher P; Fordham R; Flanagan E; Dahly D; Byrne S; Petrovic M; Gudmundsson A; Samuelsson O; Cherubini A; J Cruz-Jentoft A; Soiza RL; Eustace JA
    BMC Geriatr; 2019 Feb; 19(1):40. PubMed ID: 30760204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.